Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

No studies found 3 · 42.9%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 28.6%Moderate 2 · 28.6%High 0 · 0%

Clinical relapse · people with surgically‐induced remission in Crohn's disease

High dose 5‐ASA showed no clear difference in clinical relapse compared with low dose 5‐ASA (moderate certainty).

1 finding from 1 review

Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease 2019 · Cochrane Headline outcomes only
RR 0.65 [0.38, 1.13]
1 study · 206 participants
Moderate

Endoscopic recurrence · people with surgically‐induced remission in Crohn's disease

High dose 5‐ASA showed no clear difference in endoscopic recurrence compared with low dose 5‐ASA (moderate certainty).

1 finding from 1 review

Radiologic relapse · people with surgically‐induced remission in Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events · people with surgically‐induced remission in Crohn's disease

High dose 5‐ASA showed no clear difference in adverse events compared with low dose 5‐ASA (low certainty).

1 finding from 1 review

Serious adverse events · people with surgically‐induced remission in Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease

High dose 5‐ASA showed no clear difference in withdrawal due to adverse events compared with low dose 5‐ASA (low certainty).

1 finding from 1 review

Health related quality of life · people with surgically‐induced remission in Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found